According to our latest research, the global neurostimulation device market size reached USD 7.8 billion in 2024, with a robust compound annual growth rate (CAGR) of 11.2% projected through the forecast period. By 2033, the market is anticipated to reach USD 21.2 billion, reflecting strong momentum driven by technological advancements, expanding clinical indications, and a rising prevalence of neurological disorders. The primary growth factor remains the increasing demand for minimally invasive therapies for chronic neurological and pain conditions, coupled with favorable reimbursement scenarios in developed markets. https://growthmarketreports.com/report/neurostimulation-device-market